Gene · 619552
Papers1,546
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,546
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Beyond Macromolecules: Extracellular Vesicles as Regulators of Inflammatory Diseases. | Cells | 2023 | 37566042 | PubTator, text mining | PubMed |
| Extracellular circulating miRNAs as potential non-invasive biomarkers in non-small cell lung cancer patients. | Front Oncol | 2023 | 37546401 | PubTator, text mining | PubMed |
| Circulating noncoding RNAs: promising biomarkers in liquid biopsy for the diagnosis, prognosis, and therapy of NSCLC. | Discov Oncol | 2023 | 37526759 | PubTator, text mining | PubMed |
| Small-Extracellular-Vesicle-Derived miRNA Profile Identifies miR-483-3p and miR-326 as Regulators in the Pathogenesis of Antiphospholipid Syndrome (APS). | Int J Mol Sci | 2023 | 37511365 | PubTator, text mining | PubMed |
| RNA binding protein: coordinated expression between the nuclear and mitochondrial genomes in tumors. | J Transl Med | 2023 | 37507746 | PubTator, text mining | PubMed |
| MiR-320a upregulation improves IL-1β-induced osteoarthritis via targeting the DAZAP1 and MAPK pathways. | J Orthop Surg Res | 2023 | 37507717 | PubTator, text mining | PubMed |
| Impacts of MicroRNA-483 on Human Diseases. | Noncoding RNA | 2023 | 37489457 | PubTator, text mining | PubMed |
| Circulating mir-483-5p as a novel diagnostic biomarker for acute coronary syndrome and its predictive value for the clinical outcome after PCI. | BMC Cardiovasc Disord | 2023 | 37464313 | PubTator, text mining | PubMed |
| The Complex Relationship between Hypoxia Signaling, Mitochondrial Dysfunction and Inflammation in Calcific Aortic Valve Disease: Insights from the Molecular Mechanisms to Therapeutic Approaches. | Int J Mol Sci | 2023 | 37446282 | PubTator, text mining | PubMed |
| Transcriptome profiling and network enrichment analyses identify subtype-specific therapeutic gene targets for breast cancer and their microRNA regulatory networks. | Cell Death Dis | 2023 | 37438342 | PubTator, text mining | PubMed |
| Potential diagnostic biomarkers: 6 cuproptosis- and ferroptosis-related genes linking immune infiltration in acute myocardial infarction. | Genes Immun | 2023 | 37422588 | PubTator, text mining | PubMed |
| Glaucoma: Novel antifibrotic therapeutics for the trabecular meshwork. | Eur J Pharmacol | 2023 | 37391006 | PubTator, text mining | PubMed |
| The Link between Diabetes, Pancreatic Tumors, and miRNAs-New Players for Diagnosis and Therapy? | Int J Mol Sci | 2023 | 37373398 | PubTator, text mining | PubMed |
| Different Roles of Apoptosis and Autophagy in the Development of Human Colorectal Cancer. | Int J Mol Sci | 2023 | 37373349 | PubTator, text mining | PubMed |
| Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases. | Cells | 2023 | 37371099 | PubTator, text mining | PubMed |
| Role of hypoxia inducible factor HIF-1α in heart valves. | Glob Cardiol Sci Pract | 2023 | 37351095 | PubTator, text mining | PubMed |
| NDRG3 regulates imatinib resistance by promoting β‑catenin accumulation in the nucleus in chronic myelogenous leukemia. | Oncol Rep | 2023 | 37350410 | PubTator, text mining | PubMed |
| Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial. | Diabetes Metab J | 2023 | 37349083 | PubTator, text mining | PubMed |
| A Review of micro RNAs changes in T2DM in animals and humans. | J Diabetes | 2023 | 37329278 | PubTator, text mining | PubMed |
| Peritoneal Fluid Analysis of Advanced Ovarian Cancers after Hyperthermic Intraperitoneal Chemotherapy. | Int J Mol Sci | 2023 | 37298699 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/619552/papers?page=5